Newsroom
Sorted by: Latest
-
Samenvatting: Yoshihiro Shimamura, investeerder en ondersteuner van de Japanse entertainmentindustrie, bezoekt France Workshop tijdens het filmfestival van Cannes
OSAKA, Japan--(BUSINESS WIRE)--Shimamura Yoshihiro Film Planning Inc. (hoofdkantoor: Osaka, Japan; CEO: Yoshihiro Shimamura), een bedrijf dat zich bezighoudt met filmproductie en -investeringen, organiseert tijdens het filmfestival van Cannes van dit jaar een workshop in Frankrijk, als onderdeel van zijn streven om de entertainmentindustrie verder te bevorderen. Het bedrijf investeert in belangrijke entertainmentgerelateerde bedrijven in Japan en legt sterk de nadruk op het creëren van waarde o...
-
Riassunto: Yoshihiro Shimamura, l'investitore che supporta il settore dell'intrattenimento in Giappone, visiterà la Francia In programma un workshop durante il Festival di Cannes
OSAKA, Giappone--(BUSINESS WIRE)--Shimamura Yoshihiro Film Planning Inc. (Sede centrale: Osaka, Giappone; CEO: Yoshihiro Shimamura), una società impegnata nella produzione e negli investimenti nel settore cinematografico, ospiterà un workshop in Francia durante il Festival di Cannes di quest'anno, nell'ambito del suo impegno a promuovere ulteriormente il settore dello spettacolo. La società investe in importanti aziende associate al settore giapponese dello spettacolo, promuovendo la creazione...
-
Resumen: El inversor que apoya a la industria del entretenimiento japonesa, Yoshihiro Shimamura, visitará Francia Se realizará un taller durante el Festival de Cine de Cannes
OSAKA, Japón--(BUSINESS WIRE)--Shimamura Yoshihiro Film Planning Inc. (oficinas centrales: Osaka, Japón; director general: Yoshihiro Shimamura), una empresa que se dedica a la inversión y la producción de películas, organizará un taller en Francia durante el Festival de Cine de Cannes de este año como parte de su compromiso para seguir impulsando la industria del entretenimiento. La empresa invierte en negocios líderes relacionados con el entretenimiento en Japón y coloca especial énfasis en la...
-
Mitsubishi Electric Announces Consolidated Financial Results for Fiscal 2026
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today its consolidated financial results for fiscal 2026 (April 1, 2025 - March 31, 2026). The full document on Mitsubishi Electric’s financial results can be viewed at the following link: www.MitsubishiElectric.com/en/pr/ Consolidated Financial Results Revenue: 5,894.7 billion yen (7% increase year-on-year) Operating profit: 433.0 billion yen (11% increase year-on-year) Profit before income taxes: 526...
-
Mexedia and Donne for Peace Join Forces: A Partnership for Social and Prevention Initiatives
ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX; ISIN IT0005450819) announces the launch of a collaboration with Donne for Peace, an association active in promoting integration and inclusion through social and cultural activities aimed at women and communities. The initiative stems from the meeting of different yet complementary experiences and aims to turn concrete actions into opportunities for real participation, placing people and their e...
-
Mexedia et Donne for Peace unissent leurs forces: une collaboration pour des initiatives sociales et de prévention
ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX; ISIN IT0005450819) annonce le lancement d’une collaboration avec Donne for Peace, une association engagée dans la promotion de l’intégration et de l’inclusion à travers des activités sociales et culturelles destinées aux femmes et aux communautés. Cette initiative naît de la rencontre d’expériences différentes mais complémentaires et vise à transformer des actions concrètes en opportunités de p...
-
Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for bepirovirsen, an investigational antisense oligonucleotide (ASO) for the treatment of adults with chronic hepatitis B (CHB). The FDA has granted bepirovirsen Breakthrough Therapy designation and set a Prescription Drug User Fee Act (PDUFA) target action date of October 26, 2026. “...
-
Changi Airport Leads on Brand Strength; DBS Marks 14-Year Streak as Singapore’s Most Valuable Brand
SINGAPORE--(BUSINESS WIRE)--The nation’s top 100 brands have grown by 7% to reach a combined value of USD84.1 billion, with banking, engineering, food, and real estate sectors driving growth across the brand landscape. Singapore’s leading brands continued to strengthen amid a stable economic backdrop, according to the Singapore 100 2026 report by Brand Finance, the world’s leading brand valuation consultancy. Banking remains the most influential sector, supported by resilient balance sheets, su...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS2986720816 Our Ref. MS3889 ISSUE NAME. Australia and New Zealand Banking Group Issue of EUR 1,250,000,000.00 Floating Rate Senior Unsecured Notes due 29 October 2027 series 2146 Tranche 1 MTN INTEREST PERIOD. 29/04/2026 TO 29/07/2026 VALUE DATE. 29/07/2026 INTEREST RATE. 2.65 PCT NUM OF DAYS. 91 DAY BASIS. Actual/360 (A004) CURRENCY CODE. EUR INTEREST AMT PER DENOM. EUR 1,000.00 IS EUR 6.7 POOL FACTOR. N/A...
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from April 20 to April 24, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/...